Literature DB >> 8225866

Intraoperative 5-fluorouracil for filtration surgery in the rabbit.

J W Doyle1, M B Sherwood, P T Khaw, S McGrory, M F Smith.   

Abstract

PURPOSE: Postoperative subconjunctival injections of 5-fluorouracil (5-FU) improve the success rate of filtration surgery, but there is still a 20% or greater failure rate at 1 year in pseudophakic and repeat trabeculectomy cases. The injections are inconvenient to give and may produce corneal epithelial toxicity and other side effects. An alternative method for administration of 5-FU is investigated.
METHODS: A masked, randomized, prospective study was undertaken to compare bleb survival and complications in a rabbit model, after either a single intraoperative exposure to 5-FU (50 mg/ml concentration for 5 minutes) or five postoperative injections of 5-FU (5 mg injection on postoperative days 1, 3, 5, 7, and 9), or a combination of both, with controls that received only a 5-minute exposure to distilled water, intraoperatively.
RESULTS: For the control eyes, all blebs were "flat" to masked grading, and intraocular pressure returned to preoperative levels by postoperative day 11. In the group receiving postoperative injections of 5-FU only, blebs were flat and the pressure normalized by postoperative day 14. Rabbits receiving intraoperative 5-FU only, or combined intraoperative and postoperative 5-FU, had consistently higher blebs than the former two groups, and some blebs survived until postoperative day 25. The mean intraocular pressure remained depressed in these groups until postoperative day 21 (P < 0.05 for days 5 through 18). A combination of intraoperative and postoperative 5-FU produced significantly higher blebs than intraoperative 5-FU alone on days 7 to 14.
CONCLUSIONS: Intraoperative application of high-dose 5-FU to the filtration site either as a single 5-minute treatment, or in conjunction with postoperative injections of 5-FU greatly prolongs bleb function after filtration surgery in the rabbit.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225866

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  New model of conjunctival scarring in the mouse eye.

Authors:  M B Reichel; M F Cordeiro; R A Alexander; I A Cree; S S Bhattacharya; P T Khaw
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model.

Authors:  Zachary L Lukowski; Jeff Min; Ashley R Beattie; Craig A Meyers; Monica A Levine; Glenn Stoller; Gregory S Schultz; Don A Samuelson; Mark B Sherwood
Journal:  J Glaucoma       Date:  2013-02       Impact factor: 2.503

Review 3.  Trabeculectomy with intraoperative sponge 5-fluorouracil in Afro-Caribbeans.

Authors:  Y Lachkar; M Leyland; P Bloom; C Migdal
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

4.  Validation of the glaucoma filtration surgical mouse model for antifibrotic drug evaluation.

Authors:  Li-Fong Seet; Wing Sum Lee; Roseline Su; Sharon N Finger; Jonathan G Crowston; Tina T Wong
Journal:  Mol Med       Date:  2011-01-11       Impact factor: 6.354

5.  A new delivery system for 5-fluorouracil using prodrug and converting enzyme.

Authors:  M Akimoto; T Miyahara; J Arai; A Akimoto; H Hamada; Y Yoshida; N Yoshimura
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

6.  A novel suprachoroidal microinvasive glaucoma implant: in vivo biocompatibility and biointegration.

Authors:  Ian Grierson; Don Minckler; Marian K Rippy; Andrew J Marshall; Nathalie Collignon; Jessica Bianco; Benoit Detry; Murray A Johnstone
Journal:  BMC Biomed Eng       Date:  2020-10-14

7.  Bleb morphology and histology in a rabbit model of glaucoma filtration surgery using Ozurdex® or mitomycin-C.

Authors:  Jeffrey R SooHoo; Leonard K Seibold; Ashley E Laing; Malik Y Kahook
Journal:  Mol Vis       Date:  2012-03-26       Impact factor: 2.367

8.  Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model.

Authors:  Jeff Min; Zachary L Lukowski; Monica A Levine; Craig A Meyers; Ashley R Beattie; Gregory S Schultz; Don A Samuelson; Mark B Sherwood
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

9.  Functional proteomics of failed filtering blebs.

Authors:  Takashi Kanamoto; Nazariy Souchelnytskyi; Yoshiaki Kiuchi
Journal:  Mol Vis       Date:  2009-12-15       Impact factor: 2.367

10.  Modulating Ocular Scarring in Glaucoma Filtration Surgery Using the Epigenetic Adjunct Suberoylanilide Hydroxamic Acid.

Authors:  Cooper D Rodgers; Zachary L Lukowski; Jeff Min; Gina M Martorana; Mary-Kate Wilson; Jamie L Schaefer; Monica A Levine; Craig A Meyers; C Richard Blake; Gregory S Schultz; Mark B Sherwood
Journal:  J Curr Glaucoma Pract       Date:  2019 Jan-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.